Therapeutic effects of exendin-4 on spinal cord injury via restoring autophagy function and decreasing necroptosis in neuron

CNS Neurosci Ther. 2024 Jul;30(7):e14835. doi: 10.1111/cns.14835.

Abstract

Aims: Necroptosis is one of programmed death that may aggravate spinal cord injury (SCI). We aimed to investigate the effect and mechanism of exendin-4 (EX-4) on the recovery of motor function and necroptosis after SCI.

Methods: The SD rats with left hemisection in the T10 spinal cord as SCI model were used. The behavior tests were measured within 4 weeks. The effects of EX-4 on necroptosis-associated proteins and autophagy flux were explored. In addition, the SHSY5Y cell model was introduced to explore the direct effect of EX-4 on neurons. The effect of lysosome was explored using mTOR activator and AO staining.

Results: EX-4 could improve motor function and limb strength, promote the recovery of autophagy flux, and accelerate the degradation of necroptosis-related protein at 3 d after injury in rats. EX-4 reduced lysosome membrane permeability, promoted the recovery of lysosome function and autophagy flux, and accelerated the degradation of necroptosis-related proteins by inhibiting the phosphorylation level of mTOR in the SHSY5Y cell model.

Conclusion: Our results demonstrated that EX-4 may improve motor function after SCI via inhibiting mTOR phosphorylation level and accelerating the degradation of necroptosis-related proteins in neurons. Our findings may provide new therapeutic targets for clinical treatment after SCI.

Keywords: SHSY5Y cell; autophagy flux; exendin‐4; hemisection; necroptosis; spinal cord injury.

MeSH terms

  • Animals
  • Autophagy* / drug effects
  • Cell Line, Tumor
  • Exenatide* / pharmacology
  • Exenatide* / therapeutic use
  • Humans
  • Male
  • Necroptosis* / drug effects
  • Neurons* / drug effects
  • Neurons* / metabolism
  • Neuroprotective Agents / pharmacology
  • Rats
  • Rats, Sprague-Dawley*
  • Recovery of Function / drug effects
  • Recovery of Function / physiology
  • Spinal Cord Injuries* / drug therapy
  • Spinal Cord Injuries* / pathology
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Exenatide
  • TOR Serine-Threonine Kinases
  • Neuroprotective Agents